Virginia Bio elects five new directors to its board
Published
Virginia Bio, a nonprofit association representing the commonwealth’s life sciences industry, has elected five new members to its board of directors
The newly elected members are Elaine Horn-Ranney, Warren Martin, Dr. John Niederhuber, Chris Penet and Thomas Voss. They will serve a three-year term.
“These individuals represent strong leadership and extraordinary talent from across the commonwealth and the life sciences industry,” Jeff Conroy, chairman of the Virginia Bio board, said in a statement.
Horn-Ranney is the co-founder and CEO of Tympanogen Inc., a Norfolk-based medical device company , which sells a gel patch for the nonsurgical repair of eardrum perforations.
Martin leads the technology and life sciences practice for the Washington, D.C. office of CPA firm Cherry Bekaert.
Niederhuber is the former director of the National Cancer Institute of the National Institutes of Health. He is presently an executive vice president of the Inova Health System and CEO of the Inova Translational Medicine Institute.
Penet currently is vice president at BIO-CAT, an industrial and food enzyme firm in Troy, where he oversees planning, research and regulatory efforts.
Voss is vice president SRI Biosciences, and executive director and deputy site head at SRI International’s Shenandoah Valley Research Facility.
